{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:00:00Z","timestamp":1792083600788,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ctro.2025.100931","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T17:54:22Z","timestamp":1739296462000},"page":"100931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Comparison of 18F-FET-PET- and MRI-based target definition for re-irradiation treatment of recurrent diffuse glioma"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6670-9395","authenticated-orcid":false,"given":"Albert","family":"Everard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Versnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Ruijters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelleke","family":"Tolboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle","family":"Philippens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0857-081X","authenticated-orcid":false,"given":"Tom","family":"Snijders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Verhoeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0316-3895","authenticated-orcid":false,"given":"Szabolcs","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1672-3230","authenticated-orcid":false,"given":"Casper","family":"Beijst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2025.100931_b0005","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","article-title":"Primary brain tumours in adults","volume":"392","author":"Lapointe","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2025.100931_b0010","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-019-1775-1","article-title":"Longitudinal molecular trajectories of diffuse glioma in adults","volume":"576","author":"Barthel","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ctro.2025.100931_b0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11060-018-03059-x","article-title":"Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO)","volume":"142","author":"Navarria","year":"2019","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ctro.2025.100931_b0020","article-title":"The Value of FET PET\/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers","volume":"23","author":"Vidmar","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ctro.2025.100931_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109663","article-title":"ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma","volume":"184","author":"Niyazi","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100931_b0030","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-016-0713-8","article-title":"Suspected recurrence of brain metastases after focused high dose radiotherapy: can [18F]FET- PET overcome diagnostic uncertainties?","volume":"11","author":"Romagna","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.100931_b0035","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ctro.2025.100931_b0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.radonc.2018.10.034","article-title":"Patterns of re-irradiation for recurrent gliomas and validation of a prognostic score","volume":"130","author":"Post","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100931_b0045","article-title":"ESTRO\/EANO recommendation on reirradiation of glioblastoma","author":"Andratschke","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100931_b0050","unstructured":"Pauleit D, Stoffels G, Schaden W, Hamacher K, Bauer D, Tellmann ; Lutz, et al. PET with O-(2-18 F-Fluoroethyl)-L-Tyrosine in Peripheral Tumors: First Clinical Results. n.d."},{"key":"10.1016\/j.ctro.2025.100931_b0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/neuonc\/nos300","article-title":"[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma","volume":"15","author":"Hutterer","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ctro.2025.100931_b0060","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awh399","article-title":"O-(2-[18F]fluoroethyl)-l-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas","volume":"128","author":"Pauleit","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.ctro.2025.100931_b0065","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/neuonc\/noz180","article-title":"Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study","volume":"22","author":"Verburg","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ctro.2025.100931_b0070","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.radonc.2017.01.002","article-title":"Patterns of failure for patients with glioblastoma following O-(2-[18F]fluoroethyl)-L-tyrosine PET- and MRI-guided radiotherapy","volume":"122","author":"Lundemann","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100931_b0075","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.prro.2018.01.006","article-title":"Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma","volume":"8","author":"Hayes","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.100931_b0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.radonc.2018.08.019","article-title":"Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastoma","volume":"130","author":"Popp","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100931_b0085","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/neuonc\/nou316","article-title":"Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma","volume":"17","author":"Munck Af Rosenschold","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ctro.2025.100931_b0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.radonc.2020.06.025","article-title":"Radiotherapy target volume definition in newly diagnosed high grade glioma using 18F-FET PET imaging and multiparametric perfusion MRI: A prospective study (IMAGG)","volume":"150","author":"Dissaux","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100931_b0095","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/neuonc\/noab013","article-title":"Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET\/RANO group","volume":"23","author":"Galldiks","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ctro.2025.100931_b0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071327","article-title":"[18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET\/CT trial","volume":"13","author":"Koh","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.ctro.2025.100931_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110386","article-title":"FET PET-based target volume delineation for the radiotherapy of glioblastoma: A pictorial guide to help overcome methodological pitfalls","volume":"198","author":"Holzgreve","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100931_b0110","article-title":"MRI-based re-irradiation in recurrent glioblastoma. A prospective randomized trial","volume":"65","author":"Grosu","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ctro.2025.100931_b0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cmpb.2009.04.008","article-title":"Simultaneous multi-modality ROI delineation in clinical practice","volume":"96","author":"Bol","year":"2009","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.ctro.2025.100931_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13550-017-0295-y","article-title":"Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment?","volume":"7","author":"Unterrainer","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.ctro.2025.100931_b0125","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.1158\/1078-0432.CCR-04-0262","article-title":"Delineation of Brain Tumor Extent with [11C]l-Methionine Positron Emission TomographyLocal Comparison with Stereotactic Histopathology","volume":"10","author":"Kracht","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctro.2025.100931_b0130","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00259-018-4188-8","article-title":"FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma","volume":"46","author":"Lohmann","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ctro.2025.100931_b0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.radonc.2011.03.001","article-title":"FET-PET for malignant glioma treatment planning","volume":"99","author":"Niyazi","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100931_b0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41593-018-0285-z","article-title":"Invasion of white matter tracts by glioma stem cells is regulated by a NOTCH1-SOX2 positive-feedback loop","volume":"22","author":"Wang","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ctro.2025.100931_b0145","article-title":"CTV Delineation for High-Grade Gliomas: Is There Agreement With Tumor Cell Invasion Models? Adv","volume":"7","author":"H\u00e4ger","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.100931_b0150","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ad1997","article-title":"The influence of anisotropy on the clinical target volume of brain tumor patients","volume":"69","author":"Buti","year":"2024","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ctro.2025.100931_b0155","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1016\/j.wneu.2018.09.139","article-title":"Can Early Postoperative O-(2-18FFluoroethyl)-l-Tyrosine Positron Emission Tomography After Resection of Glioblastoma Predict the Location of Later Tumor Recurrence?","volume":"121","author":"Buchmann","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ctro.2025.100931_b0160","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-1-4939-7531-0_23","article-title":"Assessment of blood brain barrier leakage with gadolinium-enhanced MRI","volume":"1718","author":"Ku","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ctro.2025.100931_b0165","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20120414","article-title":"Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide","volume":"86","author":"Sherriff","year":"2013","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctro.2025.100931_b0170","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41582-019-0220-2","article-title":"Genetic and molecular epidemiology of adult diffuse glioma","volume":"15","author":"Molinaro","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ctro.2025.100931_b0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.radonc.2019.12.005","article-title":"Margin reduction in radiotherapy for glioblastoma through 18F-fluoroethyltyrosine PET? - A recurrence pattern analysis","volume":"145","author":"Fleischmann","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100931_b0180","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-016-0665-z","article-title":"Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume","volume":"11","author":"Piroth","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.100931_b0185","doi-asserted-by":"crossref","unstructured":"Allard B, Dissaux B, Bourhis D, Dissaux G, Schick U, Sala\u00fcn PY, et al. Hotspot on 18F-FET PET\/CT to Predict Aggressive Tumor Areas for Radiotherapy Dose Escalation Guiding in High-Grade Glioma. Cancers 2023, Vol 15, Page 98 2022;15:98. DOI: 10.3390\/CANCERS15010098.","DOI":"10.3390\/cancers15010098"},{"key":"10.1016\/j.ctro.2025.100931_b0190","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00401-007-0293-7","article-title":"Diffuse glioma growth: a guerilla war","volume":"114","author":"Claes","year":"2007","journal-title":"Acta Neuropathol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825000217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825000217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T23:36:17Z","timestamp":1762385777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630825000217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":38,"alternative-id":["S2405630825000217"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2025.100931","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of 18F-FET-PET- and MRI-based target definition for re-irradiation treatment of recurrent diffuse glioma","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2025.100931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100931"}}